DH - Definitive Healthcare Corp Price-to-Revenue Ratio

Symbol and logo of brand Definitive Healthcare Corp (DH)

Price-to-sales dynamics help identify the gap between share price and actual revenue, where 0.60 shows the current value of the metric for Definitive Healthcare (DH). The business finances rely on the marketing expenditures of pharma behemoths and the security of cloud data. Effective management of the SaaS model, combined with growing demand for commercial analytics in medicine, ensures the stable development of Definitive Healthcare (DH).

DH definitivehc.com Market Cap to Revenue (07/04/2022 - 11/14/2026)

Analytical breakdowns for Definitive Healthcare Inc. (DH)

- price and consensus price forecast:
General company analysis:DH definitivehc.com
Finished products of Definitive Healthcare Corp.

Institutional capital assesses the investment attractiveness of Definitive Healthcare (DH) through the lens of revenue multiples, which is critical for SaaS models with subscription revenue from healthcare analytics. By analyzing the historical P/S on the GURU.Markets platform, an investor compares market capitalization with sales volume to determine the asset's degree of overvaluation and the stability of the company's cash flows amid the diversification of IT risks.

Competitors of Definitive Healthcare

Price-to-Revenue Coefficient veeva.com|Doximity - Market Cap to Revenue|HealthEquity Inc - Price-to-Revenue Ratio|Waystar Inc. - P/S Multiple|Price to Sales CorVel Corp.|PRVA (Privia Health Group) - Market Cap to Revenue|huronconsultinggroup.com - Market Capitalization-to-Revenue Ratio|CERT (Certara) - P/S Multiple|OMCL: Market Capitalization-to-Revenue Ratio|P/S Multiple GDRX|SDGR - Price to Sales|P/S Multiple PHR (Phreesia, Inc.)|P/S Multiple omadahealth.com OMDA|EVH - Price-to-Revenue Ratio|HSTM: Price-to-Revenue Ratio|CCSI (Consensus) - Market Cap to Revenue|AGL: Market Cap to Sales Volume|ABSI (Absci) - P/S Multiple|SY: Market Capitalization-to-Revenue Ratio|P/S Multiple NRC|Market Cap to Revenue Spok Holdings Inc SPOK|P/S Multiple OPRX (OptimizeRx Corp.)|P/S Multiple TruBridge Corp TBRG|SLP - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio SOPH (SOPHiA GENETICS SA)|HCAT: P/S Multiple|Price to Sales CareCloud (CCLD)|RSSS (Research Solutions, Inc.) - P/S Multiple|Market Cap to Revenue Ratio DLHC (DLH Holdings Corp)|P/S Multiple ONMD|SCNX (scienture.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple HCTI (Healthcare Triangle, Inc.)|Price-to-Revenue Coefficient iSpecimen Inc (ISPC)|BFRG: Market Cap to Revenue|SCWorx Inc - Market Cap to Sales Volume|MSPR (MSP Recovery Inc) - Market Cap to Revenue|iCoreConnect - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio TRxADE HEALTH|Market Cap to Revenue Orgenesis Inc (ORGS)|P/S Multiple RCM|SHCR - Price to Sales|P/S Multiple STRM (Streamline Health Solutions)|SYRA: Market Cap to Revenue Ratio|ApolloMed - P/S Multiple|MODN (Model N Inc) - Market Cap to Revenue Ratio|NXGN: P/S Multiple